174 related articles for article (PubMed ID: 28732861)
1. Fabrication and characterization of hollow starch nanoparticles by gelation process for drug delivery application.
Yang J; Li F; Li M; Zhang S; Liu J; Liang C; Sun Q; Xiong L
Carbohydr Polym; 2017 Oct; 173():223-232. PubMed ID: 28732861
[TBL] [Abstract][Full Text] [Related]
2. Preparation of collagen peptide functionalized chitosan nanoparticles by ionic gelation method: An effective carrier system for encapsulation and release of doxorubicin for cancer drug delivery.
Anandhakumar S; Krishnamoorthy G; Ramkumar KM; Raichur AM
Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):378-385. PubMed ID: 27770906
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, characterization, release kinetics and toxicity profile of drug-loaded starch nanoparticles.
El-Naggar ME; El-Rafie MH; El-sheikh MA; El-Feky GS; Hebeish A
Int J Biol Macromol; 2015 Nov; 81():718-29. PubMed ID: 26358550
[TBL] [Abstract][Full Text] [Related]
4. Polymer-Coated Hollow Mesoporous Silica Nanoparticles for Triple-Responsive Drug Delivery.
Zhang Y; Ang CY; Li M; Tan SY; Qu Q; Luo Z; Zhao Y
ACS Appl Mater Interfaces; 2015 Aug; 7(32):18179-87. PubMed ID: 26221866
[TBL] [Abstract][Full Text] [Related]
5. A multilayer hollow nanocarrier for pulmonary co-drug delivery of methotrexate and doxorubicin in the form of dry powder inhalation formulation.
Nozohouri S; Salehi R; Ghanbarzadeh S; Adibkia K; Hamishehkar H
Mater Sci Eng C Mater Biol Appl; 2019 Jun; 99():752-761. PubMed ID: 30889750
[TBL] [Abstract][Full Text] [Related]
6. pH-Dependent doxorubicin release from terpolymer of starch, polymethacrylic acid and polysorbate 80 nanoparticles for overcoming multi-drug resistance in human breast cancer cells.
Shalviri A; Raval G; Prasad P; Chan C; Liu Q; Heerklotz H; Rauth AM; Wu XY
Eur J Pharm Biopharm; 2012 Nov; 82(3):587-97. PubMed ID: 22995704
[TBL] [Abstract][Full Text] [Related]
7. Effect of a novel shell material-Starch-protein-fatty acid ternary nanoparticles on loading levels and in vitro release of curcumin.
Zheng D; Huang C; Li B; Zhu X; Liu R; Zhao H
Int J Biol Macromol; 2021 Dec; 192():471-478. PubMed ID: 34634332
[TBL] [Abstract][Full Text] [Related]
8. Luminescent mesoporous nanoreservoirs for the effective loading and intracellular delivery of therapeutic drugs.
Kwon S; Singh RK; Kim TH; Patel KD; Kim JJ; Chrzanowski W; Kim HW
Acta Biomater; 2014 Mar; 10(3):1431-42. PubMed ID: 24239681
[TBL] [Abstract][Full Text] [Related]
9. Mulberry-like dual-drug complicated nanocarriers assembled with apogossypolone amphiphilic starch micelles and doxorubicin hyaluronic acid nanoparticles for tumor combination and targeted therapy.
Li K; Liu H; Gao W; Chen M; Zeng Y; Liu J; Xu L; Wu D
Biomaterials; 2015 Jan; 39():131-44. PubMed ID: 25477180
[TBL] [Abstract][Full Text] [Related]
10. Effect of crosslinker on drug delivery properties of curcumin loaded starch coated iron oxide nanoparticles.
Saikia C; Das MK; Ramteke A; Maji TK
Int J Biol Macromol; 2016 Dec; 93(Pt A):1121-1132. PubMed ID: 27664928
[TBL] [Abstract][Full Text] [Related]
11. Folic acid conjugated Fe
Rana S; Shetake NG; Barick KC; Pandey BN; Salunke HG; Hassan PA
Dalton Trans; 2016 Nov; 45(43):17401-17408. PubMed ID: 27731450
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxicity of folic acid conjugated hollow silica nanoparticles toward Caco2 and 3T3 cells, with and without encapsulated DOX.
Patel K; Sundara Raj B; Chen Y; Lou X
Colloids Surf B Biointerfaces; 2016 Apr; 140():213-222. PubMed ID: 26764104
[TBL] [Abstract][Full Text] [Related]
13. Poly(ethyleneglycol)-b-poly(ε-caprolactone-co-γ-hydroxyl-ε- caprolactone) bearing pendant hydroxyl groups as nanocarriers for doxorubicin delivery.
Chang L; Deng L; Wang W; Lv Z; Hu F; Dong A; Zhang J
Biomacromolecules; 2012 Oct; 13(10):3301-10. PubMed ID: 22931197
[TBL] [Abstract][Full Text] [Related]
14. Facile preparation of multifunctional hollow silica nanoparticles and their cancer specific targeting effect.
Sahoo B; Devi KSP; Sahu SK; Nayak S; Maiti TK; Dhara D; Pramanik P
Biomater Sci; 2013 Jun; 1(6):647-657. PubMed ID: 32481837
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and characterization of mesoporous magnetic nanocomposites wrapped with chitosan gatekeepers for pH-sensitive controlled release of doxorubicin.
Wu J; Jiang W; Shen Y; Jiang W; Tian R
Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):132-140. PubMed ID: 27770872
[TBL] [Abstract][Full Text] [Related]
16. Hepatoma-targeting and pH-sensitive nanocarriers based on a novel D-galactopyranose copolymer for efficient drug delivery.
Ding Y; Han J; Tian B; Han J; Zhang J; Zheng H; Han Y; Pei M
Int J Pharm; 2014 Dec; 477(1-2):187-96. PubMed ID: 25455771
[TBL] [Abstract][Full Text] [Related]
17. Fabrication and characterization of size-controlled starch-based nanoparticles as hydrophobic drug carriers.
Han F; Gao C; Liu M
J Nanosci Nanotechnol; 2013 Oct; 13(10):6996-7007. PubMed ID: 24245176
[TBL] [Abstract][Full Text] [Related]
18. Electrospray fabrication of doxorubicin-chitosan-tripolyphosphate nanoparticles for delivery of doxorubicin.
Songsurang K; Praphairaksit N; Siraleartmukul K; Muangsin N
Arch Pharm Res; 2011 Apr; 34(4):583-92. PubMed ID: 21544723
[TBL] [Abstract][Full Text] [Related]
19. Multifunctional Iron Oxide Nanocarriers Synthesis for Drug Delivery, Diagnostic Imaging, and Biodistribution Study.
Raoof F; Munawar A; Ahmad M; Rizvi SFA; Ali Z; Shahid AB
Appl Biochem Biotechnol; 2023 Jul; 195(7):4469-4484. PubMed ID: 36701093
[TBL] [Abstract][Full Text] [Related]
20. Amphiphilic Diblock Terpolymer PMAgala-b-P(MAA-co-MAChol)s with Attached Galactose and Cholesterol Grafts and Their Intracellular pH-Responsive Doxorubicin Delivery.
Wang Z; Luo T; Sheng R; Li H; Sun J; Cao A
Biomacromolecules; 2016 Jan; 17(1):98-110. PubMed ID: 26682643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
